تأثیر وضعیت بیمه بهداشت و درمان بر نتایج درمان لوسمی حاد میلوئید

Insurance source at diagnosis has no impact on AML treatment outcomes. The consistency of our results with some, but not all, studies is probably driven primarily by access-to-care eligibility requirements among different states. Further efforts to better understand such disparities are warranted.